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Clinical and Mechanistic
Issues in Early Repolarization
Of Normal Variants and Lethal Arrhythmia Syndromes
Begoña Benito, MD, Eduard Guasch, MD, Lena Rivard, MD, Stanley Nattel, MD
Montreal, Quebec, Canada
Early repolarization, involving ST-segment elevation and, sometimes, prominent J waves at the QRS-ST junction,
has been considered a normal electrocardiographic variant for over 60 years. A growing number of case reports
and case-control studies indicate that in some instances, early repolarization patterns are associated with
increased risk of idiopathic ventricular fibrillation. Epidemiological evidence indicates a dose effect for the risk of
cardiac and sudden death with the extent of J-point elevation. This paper reviews present knowledge regarding
the epidemiology, presentation, therapeutic response, and mechanisms characteristic of early repolarization. We
highlight major unanswered questions relating to our limited ability to determine which individuals with this
common electrocardiographic variant are at risk for sudden death, our incomplete understanding of underlying
mechanisms, the inadequate information regarding genetic determinants and therapeutic responses, and the
unclear relationship between early repolarization and other conditions involving accelerated repolarization and
sudden arrhythmic death such as Brugada and short-QT syndromes. This review paper intends to inform the
practicing physician about important clinical issues and to stimulate investigators to address the many unre-
solved questions in this rapidly evolving field. (J Am Coll Cardiol 2010;56:1177–86) © 2010 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.05.037l
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dudden cardiac death (SCD) is a major contributor to
opulation mortality. The most common cause of SCD is
entricular fibrillation (VF). Sudden cardiac death involves
oronary artery disease and its complications in up to 60% to
0% of cases, followed by other cardiomyopathies (1,2).
owever, in 10% to 20% of SCDs (30,000 to 60,000 deaths
nnually in the U.S.), no structural abnormalities are de-
ectable (3). Many of these are caused by primary electrical
isorders, including long-QT syndrome (4), catecholamin-
rgic polymorphic ventricular tachycardia (5), short-coupled
orsades de pointes (6), Brugada syndrome (BrS) (7), and
he short-QT syndrome (SQTS) (8), as well as cases
dentified as “idiopathic VF” (IVF) when no specific etiol-
gy is known. These unexpected deaths represent a tremen-
ous burden to families, community, and health care
roviders.
For over 60 years, ST-segment elevation in the absence of
onduction abnormalities or chest pain, occurring particu-
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ccepted May 25, 2010.arly in young, bradycardic individuals, has been considered
normal variant called “early repolarization” (ER) (9). As
ecently as 7 years ago, an analysis of over 2,000 patients
ollowed for 12 years, of whom 670 had ER, confirmed a
enign outcome and a reduced arrhythmia burden (10).
owever, a series of case reports (11–15), culminating in
ore recent larger-scale studies (16–18), suggest a more
orrisome picture, with clear over-representation of indi-
iduals with ER patterns in IVF populations. Early repo-
arization is present in5% of the population (16,18), so its
otential arrhythmic significance is very challenging. How
hould the physician advise a patient with this electrocar-
iographic variant that was until recently considered nor-
al? How can ER-related SCD be predicted and pre-
ented? What are the basic mechanisms underlying ER and
ssociated arrhythmias? In this paper, we review the avail-
ble information, focusing on possible mechanisms, clinical
eatures, and management issues, and highlight important
nanswered questions.
istorical Background
he ER pattern is defined by ST-segment elevation, often
ccompanied by slurring or notching on the terminal QRS,
alled a J-wave (Figs. 1A and 1B). This pattern was first
escribed as a normal variant by Shipley and Hallaran in
936 (19). Reports in the 1950s and 1960s confirmed with
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nign nature of what was also
called “normal RS-T segment el-
evation variant,” or “juvenile ST
pattern,” and defined character-
istic features such as predomi-
nance among male, black, young,
and physically active individuals
and regression of electrocardio-
graphic changes during exercise
(20,21).
After an initial report in 1984
(11), a growing number of case
reports in the late 1990s de-
scribed an association between
ER patterns and IVF (12–15)
and a potential basic mechanism
was suggested (22). In a large
ase-control study (16), ER was 6 times more common in
06 IVF patients than in 412 matched controls, and IVF
ubjects with ER were at increased risk of recurrent SCD. A
ery recent study of over 10,000 unselected subjects followed
or 30 years found that ER patterns are associated with
ncreased cardiac and arrhythmic mortality:2-mV inferior
T-segment elevation conferred a 3-fold risk increase for
ardiac mortality and SCD (18).
pidemiological Aspects
arly repolarization occurs in 1% to 9% of the general
opulation (10,16,18), and in 15% to 70% of IVF cases
16,17,23–25). Based on such series, ER is considered to
onvey a 4- to 10-fold SCD risk increase (16,25). In the
5 to 45 year age range of maximal ER-related SCD
ncidence (16,24,26), a J-wave is estimated to increase
VF risk from 3.4 per 100,000 to 11 per 100,000 (25).
owever, estimates based on index series of IVF cases
ay not be applicable to asymptomatic individuals with
R. In a longitudinal survey of 10,864 asymptomatic
ndividuals (age at recruitment 44  8 years, follow-up
0  11 years), arrhythmic death risk increased 1.4-fold
ith 0.1-mV and 2.9-fold with 0.2-mV J-point
levation in the inferior leads (18).
Male sex is strongly associated with ER: over 75% of
ndividuals with ER are men. Men present greater J-point
levation than women do (18,25) and represent 75% of
alignant cases (16,17). Male predominance may result
rom larger epicardial transient outward current (Ito) density
ersus Ito in women (27), although the detailed sex-related
on-channel expression profile remains to be established.
he ER pattern is more common in younger physically
ctive individuals (10,18) and may regress with aging
20,28). Estimates of the prevalence in trained individuals
ange from20% in noncompetitive athletes to 90% in elite
Abbreviations
and Acronyms
AP  action potential
BrS  Brugada syndrome
ECG  electrocardiogram
ER  early repolarization
ICD  implantable
cardioverter-defibrillator
Ito  transient outward
current
IVF  idiopathic ventricular
fibrillation
SCD  sudden cardiac
death
SQTS  short-QT syndrome
VF  ventricular fibrillationthletes. In this population, ER often appears in midrecordial leads, a pattern thought to entail more benign
utcomes. Blacks appear particularly predisposed to ER
10,20,28). Paradoxically, blacks have been under-
epresented in studies assessing malignant ER, and the
rrhythmic risk of ER among blacks is undetermined. The
nter-relations among epidemiological factors predisposing
o ER are also uncertain. For example, it is unknown
hether the roles of young age, male sex, physical activity,
nd racial predilection are related to common underlying
actors such as vagal tone and slow heart rate, or whether
ach contributes independently. The relationships between
isk factors for ER per se and SCD-associated ER are also
nclear, although male sex clearly appears to be preponder-
nt in both.
Genetic contributions to SCD-associated ER are sug-
ested by common familial SCD histories (16,26) in
ymptomatic ER patients. Geographic differences in
istribution have also been described, with ER-related
CD being particularly prevalent among South-East
sians (11,13,29).
A B
Figure 1 Electrocardiographic Pattern of Early Repolarization
Characteristic early repolarization electrocardiographic pattern, described as a
normal variant in the 1960s (A) (adapted, with permission, from Wasserburger
and It [21]), and more recently associated with idiopathic ventricular fibrillation
(B) (adapted, with permission, from Takagi et al. [14]).
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October 5, 2010:1177–86 Early Repolarization and Sudden Deathlectrocardiographic Features and Modulators
he J-point marks ST-segment onset. The degree of
-point elevation determines SCD risk (18) and increases in
-wave amplitude often precede VF episodes (16,17). Other
-wave properties may also carry prognostic information
25). A small study of 9 “malignant” ER patients (with SCD
istory) and 200 “benign” ER subjects suggested an associ-
tion of malignant ER with terminal-QRS “notching”
ersus “slurring” in left precordial leads (V4 to V5) (24). This
as not been confirmed for ER affecting inferior leads,
here the degree of J-point elevation appears to be the only
isk predictor (18).
Localization of the ER pattern could have prognostic
mplications. Case-control studies have associated aborted
CD with ER in inferior and, less commonly, lateral leads
16,26,30). Conversely, in asymptomatic individuals, ER is
ost prominent in mid–precordial leads (V2 to V4) (28), a
attern that is especially predominant among athletes and is
elieved to carry a benign prognosis. Early repolarization in
nferior leads was the sole location clearly associated with an
ncreased arrhythmic-death risk in the only large-scale
ongitudinal cohort study available (18). Combined inferior-
nd lateral-lead ER occurred in 16 cases, slightly greater
han the 10 predicted based on independence of location. In
he Haissaguerre et al. (16) case-control study, IVF-
ssociated ER manifested in inferior leads in 28, in lateral
eads in 6, and both in 30 cases.
Premature beats triggering VF can be localized to regions
howing ER and ablation of such zones can prevent IVF
ecurrence (16). Accordingly, it has been suggested that
hen multiple regions are affected on an electrocardiogram
ECG), different ventricular ectopic complex morphologies
ccur and arrhythmic risk increases (16,30).
There is no clear QT-interval difference between indi-
iduals with ER and controls (18), reinforcing the notion
hat the acceleration of repolarization in ER is local.
ignal-averaged electrocardiographic late potentials reflect-
ng conduction abnormalities are seen in 10% of IVF
atients with ER (16,17), confirming that ER is primarily a
epolarization disorder.
The ER pattern is labile: autonomic tone and heart rate
ikely play major roles in ER variability. The ER-associated
VF events are more likely to occur in vagal contexts such as
leeping or after meals (13–16,26) and J-point amplitude
ncreases at night (26). Conversely, adrenergic stimulation
uppresses ER and associated arrhythmic events (30).
hether autonomic influences are mediated exclusively
ia heart-rate change or by direct actions on ion currents
s unclear. It has been suggested that time-dependent
ecovery of Ito from inactivation could explain decreased
-wave amplitude with increased heart rate (27). Tem-
erature can also modulate J waves and ST-segment
levation; hypothermia classically induces prominent
waves (“Osborn waves”) (31). hharmacological Responses
arious pharmacological responses have been described
linically, but data from controlled trials or experimental
tudies are largely lacking. Preliminary clinical experience
ith quinidine is promising (12,32). Beta-adrenergic ago-
ists are beneficial in IVF (30,32,33), particularly for ar-
hythmic storm. Amiodarone has been reported effective in
ome patients (13), but its overall efficacy is limited (32).
everal studies suggest that Na-channel blockers such as
jmaline do not modify ER (15,17,32) or accentuate it
lightly (12,14), in contrast to the worsening typically seen
n BrS.
atient Management
o controlled studies of ER management have been pub-
ished, and recommendations are based on small series and
ase reports.
econdary prevention. For ER patients resuscitated from
VF, implantable cardioverter-defibrillator (ICD) implan-
ation is required unless contraindications apply (34). In
atients with ICDs and frequent nonsustained ventricular
achyarrhythmias and/or ICD shocks, adjuvant antiarrhyth-
ic therapy with quinidine may be helpful (17,32). No
nformation is available about lifestyle modification, but it
ay be prudent to advise highly active patients with resting
radycardia and malignant ER to reduce physical-training
rograms.
Arrhythmic storm occurs in about 10% of patients with
R-related SCD (32). Isoproterenol infusion, titrated to
ncrease heart rate beyond 90 and up to 120 beats/min,
uppresses arrhythmic events (30,32,35), as do other heart
ate-increasing interventions (such as atrial or ventricular
acing) (30,32). In patients refractory to standard therapy,
ndocardial ablation of ectopic sources in the ER zone can
e useful (16).
rimary prevention. Primary prevention of SCD in
symptomatic ER presents a major challenge. Few reliable
riteria are available to stratify SCD risk. Inferior J-point
levation 2 mm predicts a 3-fold increase in SCD risk
18). However, even this high-risk group does not diverge
rom the control population until at least 10 years after the
ndex electrocardiogram (18), so any intervention must be
ery safe, in addition to effective. Some ECG features
eflecting cardiac repolarization such as T-wave alternans
nd QT dispersion do not appear to be useful for SCD risk
tratification in ER, although evidence is scarce (26). The
R pattern diminishes and even disappears in response to
xercise both in symptomatic and asymptomatic ER pa-
ients, irrespective of ER localization (16,30). Therefore,
readmill tests do not seem to provide prognostic informa-
ion. Athletes undergoing pre-participation screening are a
roup of particular interest. Early repolarization patterns
especially in leads V2 to V6) occur in up to 90% of
igh-performance athletes (36). Whether this ER preva-
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Early Repolarization and Sudden Death October 5, 2010:1177–86ence entails an increased arrhythmic risk is unknown,
lthough mid precordial ER location is generally believed to
e benign. In the absence of reliable data, it seems unrea-
onable to recommend cessation of sports activities in
symptomatic athletes with ER (37), even at competitive
evels.
Unexplained syncope associated with an electrocardio-
raphic ER pattern is a particular problem. Both ER and
yncope are very common, affecting 5% and up to 40% of the
eneral population, respectively. As no clear stratifying criteria
re available, general guidelines for the management of syncope
pply. Familial SCD history, palpitations prior to syncope, and
yncope in the supine position point to increased risk (38). The
ensitivity of electrophysiological studies in patients with ER
nd SCD is as low as 34% (16,25). Subcutaneous recording
evices might prove useful (38).
Normal
ECG
Region A 
-80 mV
0 mV
-80 mV
0 mV
Repolariz
Depolarization
0.
APs from
0.3
QRS
T-wave
ST-segment
Region B 
APs from
Figure 2 Potential Mechanism of Early Repolarization
Action potentials recorded from regions A (red) and B (blue) are shown (top), toge
See text for discussion. AP  action potential; LV  left ventricle; RV  right ventossible Underlying Mechanisms
igure 2 provides a schematic representation of potential
echanisms producing ER. An ECG and action potentials
APs) recorded from 2 regions of the heart (A and B,
ottom) are shown. Under normal conditions (left), AP
urations are similar and small variations in the timing of
ocal depolarization and repolarization produce the electro-
ardiographic QRS complexes and T waves. During the
T-segment, all cardiac cells are depolarized, so little
urrent flows. If region A is affected by ER (right), there is
large voltage gradient between region B, which is still at
lateau potentials, and region A, which is at the resting
otential. Current flow toward the ER region creates
ositive ST-segment displacement (ST-segment elevation)
n ECG leads reflecting electrical activity in region A.
Early repolarization
LV
RV
ion A
T-wave
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ith electrocardiogram (ECG) from region A (middle).ation
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October 5, 2010:1177–86 Early Repolarization and Sudden Deathegions A and B in Figure 2 could represent different
ardiac regions or just different myocardial layers, associated
ith the development of either regional or transmural
oltage gradients, respectively.
To generate the typical ER pattern, it is necessary that
ome regions of the myocardium repolarize earlier than others:
eneralized ER would cause uniform shortening of the QT-
nterval, not the ST-segment elevation and J waves that
haracterize ER. Variations in a variety of currents can con-
ribute to such repolarization differences (39–43). Figure 3
epresents the principal ionic currents involved in the
ardiac AP. Phase 0 AP depolarization is caused by activa-
ion of the inward Na-current INa. Transient outward
-current (Ito) then initiates early (phase 1) repolarization.
ubsequently, inward L-type Ca2-current (ICaL) activation
arries depolarizing charge that supports the AP plateau
phase 2) against repolarizing K-currents. Finally, activa-
ion of delayed-rectifier currents, especially the rapid com-
onent IKr, initiates phase 3 repolarization and, in consort
ith inward-rectifier currents, repolarizes the membrane
J-wave
Epi
Endo
ICaL
INa
Ito
IKr
IKs
IKI
INa/Ca
Figure 3
Schematic Representation of APs in Epicardium
and Endocardium With the Main Underlying Ionic
Currents and Corresponding ECG
AP phases 0 to 4 are indicated. Depolarizing (inward) current are in red, repolarizing
(outward) currents in blue. Endo  endocardium; epi  epicardium; ICaL  Ca
2-
current; IKI  inward-rectifier K
-current; IKr  rapid delayed-rectifier K
-current; IK s 
slow delayed-rectifier K-current; INa  Na
-current; INa/Ca  Na
/Ca2 exchange cur-
rent; I  transient outward K-current; other abbreviations as in Figure 1.p
toack to the resting potential. Increases in repolarizing
urrent or decreases in depolarizing current accelerate
epolarization. Prominent voltage gradients early in re-
olarization produce J waves; voltage gradients later in
he AP cause ST-segment elevation. In arterially perfused
anine ventricular-wedge samples, J waves are associated
ith phase 1 voltage gradients between endocardium and
picardium (39), which develop due to the smaller Ito
ensity present in endocardium compared with epicardium
r mid-myocardium (40). In the same model, ST-segment
levation can be induced by administration of IKATP openers
r Ca2-channel blockers, the effects of both currents
xtending beyond phase 1 to the plateau phase (27).
The mechanisms of ER-induced arrhythmias are incom-
letely understood. Figure 4 presents one possible scenario
44). If ER is accelerated with a large Ito, phase 1 notch
ncreases and/or all-or-none repolarization can occur, pro-
ucing large voltage gradients. These voltage gradients can
nitiate arrhythmogenesis, either by propagation of the AP
ome (“phase 2 re-entry”) (41) or via boundary currents
nalogous to “injury currents” in acute myocardial infarction
42) that raise ER cells to threshold and induce spontaneous
ctivity.
The first gene variants described in patients with ER and
CD agree with the notion of ionic-current imbalances
avoring accelerated repolarization as causes of the charac-
eristic ECG pattern and arrhythmia susceptibility. The first
utation identified in a patient with ER-related VF was
ound in the KCNJ8 gene encoding the inward-rectifier
TP-dependent K-channel (35). No functional studies are
vailable for this variant. Preliminary results indicate a loss-of-
unction mutation in CACNB2B, an accessory Ca2-channel
ubunit, in 1 of 8 genotyped ER patients (43).
Mechanistic considerations may explain clinical aspects of
R. J waves are enhanced by hypothermia, which can also
ause VF (39). Ionic currents have characteristic tempera-
ure sensitivities (45), potentially accounting for hypother-
ic J waves. Most ionic currents show time-dependent
ctivation, inactivation, and/or recovery properties and are
trongly influenced by heart-rate changes (46), potentially
ccounting for rate-dependent ER manifestations. The
enefit from quinidine is generally attributed to Ito inhibi-
ion, which is consistent with the notion that early phase 1
oltage gradients underlie arrhythmogenesis, although
uinidine blocks a variety of ion currents including delayed-
ectifier K-currents and Na-current as well as Ito.
elation to Other SCD Syndromes With ER
esides acute myocardial ischemia, an acquired condition
hat accelerates repolarization and causes SCD (47), BrS
nd SQTS also cause early repolarization and IVF. The
asic features of BrS, SQTS, and ER syndrome are sum-
arized in Table 1 (48–50).
Brugada syndrome is defined by a characteristic ECGattern including ST-segment elevation in right precordial
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Early Repolarization and Sudden Death October 5, 2010:1177–86eads (7), is often associated with terminal conduction
lowing, and has been closely linked to mutations affecting
a-channel function, with some cases involving genes
ncoding ICaL and Ito (51–56). Furthermore, BrS alters cell
epolarization, although whether this is a primary effect or is
econdary to underlying depolarization disorders remains
ontroversial (57). The right precordial dominance in BrS
ay relate to greater right-ventricular Ito density compared
ith other cardiac regions (58). The SQTS, with wide-
pread AP-duration decreases reflected by QT-interval
hortening, is caused by gain-of-function K-channel mu-
ations and less commonly loss-of-function Ca2-channel
utations (8,59–61).
There is considerable overlap between the various syn-
romes involving accelerated repolarization, and it has been
uggested that they be encompassed by the general term
J-wave syndromes” (27). Presumed loss-of-function muta-
ions in Ca2-channels have been described in BrS, SQTS,
nd ER syndrome (43,53). Gain-of-function mutations in
Kr and IKs subunits, classically related to SQTS, were
ecently also associated with ER (62,63). Early repolariza-
Epi2
Epi1
E
Ep
Endo
A
B
Figure 4 Potential Mechanism for Early Repolarization Arrhythm
(A) With enhanced repolarization in regions with prominent Ito, all-or-none repolariz
tials from 2 epicardial (Epi1 and Epi2) and 1 endocardial site (Endo), and surface E
propagation of the dome from Epi2 to Epi1, inducing re-entry. Adapted, with permision patterns are common in SQTS patients and reflect arrhythmic risk (62). Both BrS and ER syndrome have been
escribed simultaneously in the same individual or in
ifferent members of the same family (14). Among patients
ith BrS, an ER pattern in inferolateral leads is found in
1% to 15% of cases (64–66). Whether the presence of ER
ncreases the arrhythmic risk in patients with BrS remains
ontroversial. One publication reported a 4-fold increase in
rrhythmia recurrence in patients with BrS and ER (66),
ut the findings differ in other series (65).
nresolved Issues
erhaps the most striking aspect of the rapidly evolving data
egarding ER is the questions they raise about the patho-
hysiology and clinical significance of the ER pattern and
bout the broader range of arrhythmic conditions involving
ccelerated repolarization. We will highlight these by re-
urning to questions raised in the introduction.
hat are the basic mechanisms underlying ER and
ssociated arrhythmias? Although some data are available
rom experimental models, many questions about the mech-
Transmural 
voltage 
gradient 
Endo
nesis
can occur, creating a substrate for arrhythmias. (B) Simultaneous action poten-
loss of the action potential dome in Epi1, but not in Epi2, leads to apparent
rom Yan et al. (44). Abbreviation as in Figure 2.pi2
i1
oge
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sion, fnisms of ER-related arrhythmogenesis remain unan-
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October 5, 2010:1177–86 Early Repolarization and Sudden Deathwered. Recent studies (25–27) have placed great emphasis
n the J-wave as an indicator of arrhythmic risk. However,
he pathophysiological role of events corresponding to the
-wave is unclear. The J-wave occurs immediately after
epolarization, very early in the ST-segment, whereas ER-
ssociated ventricular tachyarrhythmias usually begin much
ater, close to the T-wave. Consider the speculation based
n theoretical possibilities illustrated in Figure 5: panel A
Transmural 
voltage 
gradients 
EndoEpi2
Epi1
EndoEpi2
Epi1
T-wave
J-wave
A
B
C
ST-segment
ST-segm
Figure 5 ER Effects on Action Potentials and ECG, Illustrating
(A) Early repolarization (ER) can enhance phase 1 notch (Epi2) or cause all-or-none
J-wave. (C) All-or-none repolarization does not cause J-wave but produces large tra
potentially causing ectopic activity (dashed lines). (D) Variable AP repolarization re
as in Figures 2 and 3.
nherited SCD Syndromes Involving ERTable 1 Inherited SCD Syndromes Involving ER
ER Syndrome
Gene mutations/ion current KCNJ8/IKATP (35)
CACNA1C, CACNB2B/ICaL (43)
ECG J-wave; ST-segment elevation
Drug therapy Quinidine (16)
Isoproterenol (15)
CG  electrocardiogram; ER  early repolarization; SCD  sudden cardiac death.hows an endocardial and 2 epicardial APs reproduced from
igure 4. One epicardial cell (Epi2) shows a typical spike-
nd-dome pattern with accentuated phase 1 repolarization,
hereas the other (Epi1) has undergone all-or-none repo-
arization directly from phase 1, showing early phase 3
epolarization. Figure 5B and 5C illustrate the expected
lectrocardiographic consequences of Epi1 or Epi2 APs.
isplacements in the ST-segment result from voltage gra-
Endo
EndoEpi2
Epi1
ve
D
T-wave
J-wave
ST-segment
otential Role of J-Wave as a Marker of ER Risk
arization from phase 1 (Epi1). (B) Enhanced phase 1 notch causes prominent
al repolarization gradients that persist when Epi1 APs have regained excitability,
es to ER generates both prominent J waves and ectopic activity. Abbreviations
Brugada Syndrome Short-QT Syndrome
SCN5A, SCN1B, SCN3B/INa (51,54,55)
GPD1-L/INa (52)
CACNA1C, CACNB2B/ICaL (53)
KCNE3/Ito (55)
KCNH2/IKr (59)
KCNQ1/IKs (60)
KCNJ2/IK1 (61)
CACNA1C, CACNB2B/ICaL (53)
J-wave; ST-segment elevation Short-QT; peaked T waves
Quinidine (48)
Isoproterenol (49)
Quinidine (50)T-wa
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Early Repolarization and Sudden Death October 5, 2010:1177–86ients illustrated by the violet arrows. Epi2 APs have a large
oltage gradient early in repolarization and generate large J
aves (Fig. 5B); the voltage gradient then rapidly decreases,
esulting in little ST-segment elevation. In contrast, Epi1
Ps produce an increasing voltage gradient during the
T-segment (Fig. 5C). Because the voltage gradient con-
inually increases between phases 1 and 3 of Epi1, there
ould be no discrete J-wave but considerable ST-segment
levation, and the large depolarizing voltage gradient fol-
owing Epi1-repolarization could reactivate Epi1 cells lead-
ng to early coupled ectopy (dashed lines). A combined
cenario with heterogeneous accelerated repolarization is
llustrated in Figure 5D, with some cells showing deep
otches and others all-or-none repolarization from phase 1,
roducing prominent J waves along with ST-segment ele-
ation and arrhythmogenesis. The enhancement of the AP
ome that can occur with Epi2 APs increases the risk by
reating large intraepicardial voltage gradients. In addition,
teep repolarization gradients could produce unidirectional
lock and re-entry in response to focal ectopic activity. In
his schema, J waves might be markers of ER arrhythmia
isk, rather than directly reflecting the arrhythmogenic
echanism. Figure 4 shows another notion of arrhythmo-
enesis in ER more directly implicating the J-wave, with
ropagation of the AP dome causing phase 2 re-entry.
Another important issue is the unknown basis of regional
R. Why is ER located primarily in inferior leads in some
ndividuals and lateral leads in others? Localization must
eflect regional control of repolarization, which is presently
oorly understood. In most studies of ER, only patients
ith inferior or lateral ER are considered (16,18), presum-
bly to avoid contamination with BrS patients. However,
his begs the question of whether some (perhaps many) BrS
atients simply have a right precordial variant of ER.
triking similarities between ER and BrS include male
redominance, peak of SCD incidence at the fourth decade
f life, slow heart-rate dependence, and favorable responses
o quinidine and isoproterenol. However, the clear accen-
uation typically produced by Na-channel blockers in BrS
s not seen in ER (12,14,15,17,32), highlighting probable
ifferences in underlying ionic mechanisms. It is also in-
riguing that the J-wave was initially considered a depolar-
zation event: is it possible that the right precordial terminal
onduction slowing typical of BrS patients is in some cases
imply a J-wave? Despite extensive investigation, only about
0% of BrS patients have detectable mutations, most affect-
ng Na-channel function. Could many genotype-negative
rS patients simply be right precordial ER variants?
ow can ER-related SCD be predicted and prevented? At
he moment, we have data about the characteristics of
alignant ER patients presenting with SCD, and some
nowledge about apparently healthy individuals with ER.
owever, we have very little information connecting the
wo. A crucially important issue is whether there are two
iscrete populations, one with benign ER (a true normal
ariant with no risk of adverse outcomes) and another with ralignant ER at risk of SCD, or whether all individuals
howing ER are at risk of SCD under appropriate circum-
tances. Further longitudinal and observational studies com-
aring malignant ER patients with asymptomatic ER con-
rols are needed to clarify their relative characteristics.
tudies of genetic variability could be particularly valuable in
efining gene variants that distinguish benign from malig-
ant ER, providing insights into risk prediction, racial, and
ex features, and pathophysiological mechanisms. Gene-
xpression profiling may provide new insights into the
echanisms underlying ER syndromes, including the role
f regional and gender-related factors, and may eventually
e of diagnostic and prognostic value (69–71). Athletic
ctivity and high-level training strongly predispose to ER,
et the incidence of IVF in trained athletes is fairly low.
oes this support the notion that individuals with benign
R are not at risk? Are there individuals at risk of malignant
R for whom exercise training must be prohibited?
The prevention of ER-related SCD is closely related to
ccurate risk stratification. In addition, it presumes effective
reventive measures. At present, the only definite way to
revent SCD is with ICDs. These can only be justified in
ndividuals at very high risk, such as survivors of ER-related
CD. The identification of other high-risk ER subgroups
eriting ICD implantation would be helpful. However, less
ggressive approaches for individuals at lower risk would
lso be desirable. Quinidine’s efficacy has been attributed to
to inhibition, but the basis of its efficacy is unclear because
uinidine also affects other currents. It is presently feasible
o develop highly selective Ito blocking compounds (67,68),
hich might prevent SCD in a range of ER-associated
onditions (e.g., acute myocardial infarction, BrS, SQTS,
nd malignant ER) and provide an important test of
resumed pathophysiology. Further insights into the role of
eart rate and autonomic tone are needed. Bradycardia as an
xaggerator of ER could explain ER enhancement in
thletes and nocturnal occurrence of ER-associated SCD;
achycardia could account for the ER-reducing effects of
xercise and enhanced adrenergic tone. If so, pacemaking to
revent bradycardia or increase resting heart rate might be
ndicated in some at-risk individuals. The direct role of
onic-current modulating effects of autonomic tone (15,22)
equires investigation. Heart rate-independent autonomic
ffects would have specific therapeutic implications.
ow should the physician advise a patient with this ECG
ariant that was until recently considered normal? Pre-
ent knowledge is inadequate for detailed counseling of
symptomatic individuals with ER patterns. The overall risk
s low, but epidemiological studies (18) suggest that it is not
, and SCD is such a devastating event that even a small risk
s disturbing. This issue has complex human, medical, and
otential legal implications and further research, of the type
iscussed, is essential to clarify the outcome predictors in
symptomatic ER subjects. For now, asymptomatic young
nd physically active individuals, particularly those with ER
estricted to precordial leads, can be reassured that the
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eed to be able to more accurately estimate risk in all ER
ubjects, offer preventive therapy when risk is elevated, and
nderstand underlying mechanisms to move forward in risk
tratification and management. Clearly, there is a lot of
ork to do.
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